-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Imax, Raises Price Target to $60

Benzinga·10/14/2026 12:34:39
Wedbush analyst Alicia Reese maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $54 to $60.